Xgene Pharmaceutical, a Shanghai-based pharmaceutical start-up, has raised US$20 million in series B round of financing led by Ping An Ventures. Zhongtai Investment, a subsidiary of Indonesia-based Sinar Mas Group, and existing investors including Morningside Venture Capital and TF Capital also participated in this round. Founded in 2016, Xgene Pharmaceuticals is dedicated towards the treatment […]

Chinese Pharmaceutical Start-Up Xgene Raises $20M In Series B Round appeared first on China Money Network.